Beware the month of August – when Congress and many citizens are vacationing! Government bureaucrats favor August to issue announcements about radical medical research policy changes, for which taxpayer money is sought. They do so, to avoid public controversy about public funding of radical experimentation…
Stakeholders in the Medical research enterprise, in the European Union and in the U.S., claim that clinical trials conducted on human subjects adhere to strict safety standards. “One of the things that sets clinical trials apart from other scientific experiments is the . . . Continue reading →
A scientific study that tested three different retreoviral drugs and vaginal gel in more than 5,000 HIV-negative women in Uganda, South Africa and Zimbabwe, FAILED to demonstrate the drugs’ effectiveness in preventing HIV. Continue reading →
About 30 women who participated in a clinical trial have been left hundreds of particles of potentially hazardous metal in their breast by a faulty disk made of tungsten and silicone that was used to shield against radiation exposure.
Another Child Devloped Cancer: SCID Trials Suspended – ABC Tue, 14 Jan 2003 ABC News reports that the FDA suspended 30 gene therapy trials after a second child developed leukemia. So far, two boys who had undergone the experimental gene therapy treatment . . . Continue reading →
Recent developments in gene transfer research: risk and ethics Mon, 10 Jan 2005 An analysis by Dr. Jonathan Kimmelman, in the British Medical Journal provides an illuminating, clearly articulated discussion about the ethical dilemmas that challenge gene transfer experiments – essentially a . . . Continue reading →
Bad Medicine – Editorial – Guardian UK Sat, 12 Jun 2004 New York State Attorney General, Eliot Spitzer, is being recognized as a hero on both sides of the Atlantic. That’s because, unlike FDA officials, he knows how to use a “smoking . . . Continue reading →
July 26, 2002 Cancer Trials: 60% to 70% of subjects are children – Wall Street Journal The Wall Street Journal reports that there is a shortage of people volunteering to test experimental cancer drugs. “Overall, only 3% to 4% of cancer patients . . . Continue reading →
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do." Continue reading →
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital.  http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm It airs momorrow. Continue reading →
"As long as we continue to manipulate biology in new ways, we probably cannot prevent all such events from occurring. We must do what we can to minimize risk, but the future health of the world population demands that we not let adverse events put an end to medical progress." Continue reading →
A study published in The Journal of the National Cancer Institute, found that advanced chemotherapy put patients at far greater
risks of harm than adverse effect reports from clinical trial data reveal.